Prostaglandin E2: The master of endometriosis?

Meng Hsing Wu, Chun Wun Lu, Pei Chin Chuang, Shaw Jenq Tsai

Research output: Contribution to journalShort surveypeer-review

112 Citations (Scopus)


Endometriosis is the primary cause of infertility in women, with a prevalence rate ranging from 5% to 10%. Women with endometriosis suffer from symptoms such as chronic pelvic pain, dysmenorrhea and dyspareunia, which significantly reduce the quality of life. Endometriosis is a polygenic disease with a complex, multifactorial etiology. The mechanism responsible for the initiation and development of this disease remains largely unknown. Prostaglandin E2 (PGE2), a versatile eicosanoid that exerts numerous physiological and pathological functions, has been implicated to play critical roles in the development of endometriosis. A growing body of evidence demonstrates that PGE2 regulates many pathophysiological processes including cell proliferation, antiapoptosis, immune suppression and angiogenesis during the development of endometriosis. This review focuses on recent advances in cellular and molecular mechanisms triggered by PGE 2 that contribute to the pathological processes of endometriosis.

Original languageEnglish
Pages (from-to)668-677
Number of pages10
JournalExperimental Biology and Medicine
Issue number6
Publication statusPublished - 2010 Jun

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Prostaglandin E2: The master of endometriosis?'. Together they form a unique fingerprint.

Cite this